EAU23: il progresso

EAU2023 è giunto al termine. Le sessioni scientifiche hanno dimostrato i costanti e solidi progressi che EchoLaser sta facendo come punto di svolta per il trattamento della BPH: Il primo studio clinico randomizzato vs TURP mostra che il 96% dei pazienti trattati con...

EchoLaser SoracteLite TPLA: now on RAI national TV

TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology. Prof. Bove was one of the first users of EchoLaser and is the principal...

SoracteLite in UK

Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years. Patients can scan a QR Code and book a free...